Patent · US Active

Indolinone analogues

US9102684B2 · kind B2 · utility

2Cited by

0References

14Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Harald Engelhardt · Ebreichsdorf, AT
Davide Gianni · Wien, AT
Andreas Mantoulidis · Wien, AT
Christian Alan Paul Smethurst · Wien, AT

Key dates

Filing date	Mar 26, 2014
Grant date	Aug 11, 2015
Priority date	—
Expiry date	Mar 26, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (I)wherein the groups R1 to R4, A1 and A2 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.